A ground breaking study using artificial intelligence is taking place at a London hospital.

The COVID19 outbreak has changed the world faster than anyone could have imagined. Forced isolation has shifted meetings and activities to go on through web collaboration tools. Arguably most importantly, the virus has ground the entire economy to a halt. For some industries (travel, retail, food services, fitness), unemployment is already rampant, and for more remote-friendly industries (tech, media), work may go on, but sales are slowed or frozen, and receivables less likely to convert to revenue than ever. The downsides of the virus are easy to see – but business and public sector leaders are forced to think about the silver lining.

The COVID-19 pandemic is the greatest global healthcare crisis of our generation, presenting enormous challenges to medical research, including clinical trials. Advances in machine learning are providing an opportunity to adapt clinical trials and lay the groundwork for smarter, faster and more flexible clinical trials in the future. In an article published in Statistics in Biopharmaceutical Research, an international collaboration of data scientists and pharmaceutical industry experts – led by the Director of the Cambridge Centre for AI in Medicine, Professor Mihaela van der Schaar of the University of Cambridge – describe the impact that COVID-19 is having on clinical trials, and reveal how the latest machine learning (ML) approaches can help to overcome challenges that the pandemic presents. The paper covers three areas of clinical trials in which ML can make contributions: in trials for repurposing drugs to treat COVID-19, trials for new drugs to treat COVID-19, and ongoing clinical trials for drugs unrelated to COVID-19. The team, which includes scientists from pharmaceutical companies such as Novartis, notes that'the pandemic provides an opportunity to apply novel approaches that can be used in this challenging situation.'

The COVID-19 Coronavirus era began from its epicenter in China and has spread over all the cities and countries of the world. Might be there is no country which hasn't got the effects of this life taking virus. "The novel coronavirus to date has infected more than 30 lacs people out of which more than 2 lacs have died and 9 lacs are recovered." All these figures are from the WHO reports. The governments of all countries have imposed lockdowns due to which the economic activity has slowed throughout the world.

BANGKOK- As the coronavirus pandemic leads to anxiety over the strength of the world's food supply chains, everyone from governments to banks are turning to the skies for help. Orbital Insight, a California-based big data company that uses satellites, drones, balloons and mobile phone geolocation data to track what's happening on Earth, has seen inquiries about monitoring food supplies double in the past two months, according to James Crawford, founder and chief executive officer of the company. "We're helping supply chain managers, financial institutions, and government agencies answer questions they never thought they would have to ask," Crawford said in a phone interview. The coronavirus outbreak has triggered a fresh surge in demand for alternative data to shed light on how the pandemic is impacting industries and trade across the globe. That is especially important as multiple government lockdowns and tighter restrictions on the movement of people and goods upend supply chains and logistics everywhere from Asia to Europe and the Americas. Orbital customers have been asking for data such as when cargo ships leave ports, when plants close, and the number of passengers travelling through airports.